Navigation Links
Gene therapy for metastatic melanoma in mice produces complete remission
Date:11/18/2010

INDIANAPOLIS A potent anti-tumor gene introduced into mice with metastatic melanoma has resulted in permanent immune reconfiguration and produced a complete remission of their cancer, according to an article to be published in the December 2010 issue of the Journal of Clinical Investigation. The online version is now available.

Indiana University School of Medicine researchers used a modified lentivirus to introduce a potent anti-melanoma T cell receptor gene into the hematopoietic stem cells of mice. Hematopoietic stem cells are the bone marrow cells that produce all blood and immune system cells.

The T cell gene, which recognizes a specific protein found on the surface of melanoma, was isolated and cloned from a patient with melanoma. The gene-modified stems cells were then transplanted back into hosts and found to eradicate metastatic melanoma for the lifetime of the mice.

"We found that the transplantation of gene-modified hematopoietic stem cells results in a new host immune system and the complete elimination of tumor," reported Christopher E. Touloukian, M.D., an assistant professor of surgery and immunology at the IU School of Medicine and a member of the Indiana University Melvin and Bren Simon Cancer Center. "To date, cancer immunotherapies have been hampered by limited and diminishing immune responses over time. We believe this type of translational model opens new doors for patients with melanoma and potentially other cancers by taking advantage of the potent regenerative capacity of hematopoietic stem cells and new advances in gene therapy."

This research was funded by a National Institutes of Health grant.

It has paved the way for a new clinical trial in humans funded by the V Foundation for Cancer Research. The pilot phase I trial will involve treatment of 12 patients and focus primarily on the safety and efficacy of the therapy, said Dr. Touloukian, who is the senior author on the JCI paper and the principal investigator for the clinical study. The clinical trial is expected to begin accruing patients by late 2011.

In 2010, more than 68,000 patients will be diagnosed with melanoma and the disease will be associated with approximately 9,000 deaths. The state of Indiana has the 11th highest rate of melanoma incidence of all 50 states. Current treatments for metastatic melanoma, though exciting and innovative, have been highly toxic and largely unsuccessful with the most patients dying within 6 to 12 months after diagnosis.


'/>"/>

Contact: Mary L. Hardin
mhardin@iupui.edu
317-274-7722
Indiana University School of Medicine
Source:Eurekalert  

Related medicine news :

1. Neuralstem files FDA application for first drug therapy
2. Combination therapy improves survival time for patients with advanced liver cancer
3. Gene Therapy Shows Potential Against Heart Failure
4. Hearing loss common following radiation therapy for head and neck cancer
5. Targeted therapy reactivates guardian of the genome in resistant cancer
6. GUMC: fMRI predicts outcome to talk therapy in children with an anxiety disorder
7. Colorectal cancer risk increases in prostate cancer patients on androgen deprivation therapy
8. Fracture Risk Seen With Hormone Therapy for Prostate Cancer
9. Menopausal hormone therapy may increase risk of ovarian cancer
10. Side effects of hormonal breast cancer therapy increased; may affect treatment adherence
11. Potential drug therapy for diabetic retinopathy under study
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Gene therapy for metastatic melanoma in mice produces complete remission
(Date:1/20/2017)... (PRWEB) , ... January 20, 2017 , ... “Code Word: Chocolate Biscuit”: a biographical account ... Word: Chocolate Biscuit” is the creation of published author, Marlyn Ivey, born in Lynn Haven, ... he went to school and at 19 years of age, he joined the Navy and ...
(Date:1/20/2017)... ... , ... “Journey to Christmas:” a beautiful and enchanting tale that teaches children the true meaning ... of three in Oklahoma City, and a devoted woman of faith. , “Becoming a ... in the back of my mind for years, but actually doing it might have been ...
(Date:1/19/2017)... ... ... the Centers for Medicare & Medicaid Services (CMS) announced over 359,000 clinicians are ... who participate in APMs are paid for the quality of care they give to ... a system that delivers better care and one in which clinicians work together to ...
(Date:1/19/2017)... ... ... the cold weather here, many people will have to clear snow with snow blowers or ... snow, but they can be dangerous when used incorrectly. That’s why Amica Insurance ... use of snow blowers:, , When removing wet snow or debris ...
(Date:1/19/2017)... Melville, New York (PRWEB) , ... January 19, ... ... state–of-the-art high definition dynamic telemedicine solutions, has recently unveiled impressive transportable capabilities with ... this newly designed product is an extension to RMT technology that delivers HD, ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... global  pacemaker market  is expected to reach USD 12.3 billion by 2025, according ... cardiac conditions coupled with the availability of medical coverage is a key driving ... devices are supporting the expansion of this vertical. ... ... Logo ...
(Date:1/19/2017)... Jan. 18, 2017  ViewRay, Inc. (Nasdaq: ... and only clinical MRI-guided radiation therapy system, announced today ... approximately $26.1 million through a private placement of ... led the financing and was joined by certain ... and Kearny Venture Partners, and an additional new ...
(Date:1/19/2017)... Calif. , Jan. 18, 2017  Magnetic ... solutions has entered into an agreement with inviCRO ... the Momentum MPI imaging system based on inviCRO,s ... will be distributed as a complete MPI solution ... enable quantitative nanoparticle or cell imaging in vivo. ...
Breaking Medicine Technology: